Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
3
|
| gptkbp:bfsParent |
gptkb:Ninjutsu
|
| gptkbp:activities |
inhibits ornithine decarboxylase
|
| gptkbp:appointed_by |
gptkb:skincare_product
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:clinical_trial |
conducted for cancer treatment
|
| gptkbp:developed_by |
gptkb:Sanofi
|
| gptkbp:discovered_by |
gptkb:1980s
|
| gptkbp:formulation |
gptkb:skincare_product
|
| https://www.w3.org/2000/01/rdf-schema#label |
eflornithine
|
| gptkbp:ingredients |
C8 H10 N2 O5
|
| gptkbp:invention |
patented
|
| gptkbp:is_known_for |
DFMO
|
| gptkbp:is_used_for |
treatment of African sleeping sickness
|
| gptkbp:marketed_as |
Vaniqa
|
| gptkbp:side_effect |
skin irritation
|